This comprehensive course provides healthcare professionals with detailed knowledge of topical treatments for skin cancer and the medico-legal considerations involved in treating skin cancer patients. Divided into two key units, it covers both clinical and legal aspects to enhance patient care and protect practitioners from legal pitfalls.
Unit 1: Topical Treatments for Skin Cancer
This unit focuses on the use of two key topical treatments: Imiquimod and 5-fluorouracil (5-FU). These creams are effective for treating superficial basal cell carcinoma (BCC), actinic keratosis, and Bowen's disease. Participants will learn how to apply these treatments, adjust dosages, and monitor patient responses. Detailed guidance is provided on managing side effects and optimizing patient outcomes. The unit also highlights the use of these topical agents as an alternative to surgical or destructive treatments, particularly in field therapy and specific high-risk cases.
Unit 2: Medico-Legal Considerations in Skin Cancer Treatment
This unit covers critical medico-legal issues in skin cancer medicine. Topics include the importance of maintaining comprehensive medical records, obtaining informed consent, and implementing proper follow-up systems. It discusses common medico-legal challenges, such as failure to diagnose and inadequate treatment, and emphasizes the need for clear, legible documentation. The unit also provides practical tips for managing high-risk cases and offers insights into the consequences of poor record-keeping and failure to adhere to standard care protocols.
This course equips general practitioners with the tools to effectively manage both the clinical and legal aspects of skin cancer medicine, ensuring better patient outcomes and legal protection.
All degree qualified medical practitioners.